Bob Tufts is a longtime reader of this blog (and my old blog), as well as an email and Twitter correspondent and fellow Primate over at Baseball Think Factory.
He also happens to be a former major leaguer who played for the Kansas City Royals.
He also has been undergoing cancer treatment for a long while and, in light of the news about Harmon Killebrew and his former teammate Paul Splittoroff, is wondering what the hell the deal is with former Royals and cancer:
This news hits me pretty hard and very close to home. Paul was a teammate in 1982 and 1983 in Kansas City, and I also have been afflicted with cancer. As of now I am doing well in my post-autologous stem cell transplant battle with multiple myeloma thanks to the good doctors at Weill Cornell/New York Presbyterian Hospital.
I immediately thought about many other members of the circa 1980 Royals team that had died due to cancer. Manager Dick Howser died in 1987 from a malignant brain tumor, reliever Dan Quisenberry died in 1989 from a brain tumor, reliever Ken Brett (albeit only in KC from 1980-81) died in 2003 after a prolonged battle with brain cancer. Now Splitt – and me. And Killebrew actually played his last season in the majors in Kansas City in 1975.
While acknowledging that he doesn’t and can’t have access to any more than anecdotal information, Bob notes that there seems to be an abnormal number of cancer diagnosis among ballplayers, especially former Royals. He suggests that the MLBPA and Major League Baseball study cancer rates and types among former major leaguers. It’s not a bad suggestion.
Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.
It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.
Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.
A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.